Market Commentary: November 10, 2020

Erin O'Boyle2020-11-11T17:24:33-05:00November 10th, 2020|

This week, Pfizer announced that their coronavirus vaccine is more than 90 percent effective at preventing Covid-19 infections. How has the market responded to this news? In this week’s HaverCast, Tim Hoyle, Chief Investment Officer, looks at the divergence of market performance and “Covid stocks” vs. “vaccine stocks.”

These comments are provided as a general market overview and should not be relied upon as a forecast, research or investment advice, and is not a recommendation, offer, or solicitation to buy or sell any securities or to adopt any investment strategy. Opinions expressed are as of the date noted and may change at any time. The information and opinions are derived from proprietary and non-proprietary sources deemed by Haverford to be reliable, but are not necessarily all-inclusive and are not guaranteed as to accuracy. Index returns are presented for informational purposes only. Indices are unmanaged, do not incur fees or expenses, and cannot be invested in directly.
Investments in Securities are Not FDIC Insured · Not Bank Guaranteed · May Lose Value

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively.

Market Commentary: November 10, 2020

Contact Haverford

To protect your privacy, please do not include any non-public personal information on this contact form. If you correspond with us via the internet, we cannot guarantee the security of information you provide.